Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future.
about
Advances in sickle cell therapies in the hydroxyurea eraMinor antigens on transfused RBCs crossprime CD8 T cells but do not induce full effector functionMagnetic resonance imaging in pediatric sickle cell anemia.Psychosocial impact of sickle cell disorder: perspectives from a Nigerian settingDevelopment of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium.Fertility preservation in patients with haematological disorders: a retrospective cohort study.Pediatric hematology providers on referral for transplant evaluation for sickle cell disease: a regional perspective.Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer.Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigensCTLA4-Ig prevents alloantibody production and BMT rejection in response to platelet transfusions in mice.Mechanisms of alloimmunization and subsequent bone marrow transplantation rejection induced by platelet transfusion in a murine model.Fetal hemoglobin reactivation and cell engineering in the treatment of sickle cell anemia.Hematopoietic stem cells: transcriptional regulation, ex vivo expansion and clinical application.FK228 Analogues Induce Fetal Hemoglobin in Human Erythroid Progenitors.Amelioration of murine sickle cell disease by nonablative conditioning and γ-globin gene-corrected bone marrow cells.Transfusion of minor histocompatibility antigen-mismatched platelets induces rejection of bone marrow transplants in mice.Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model.Umbilical cord blood transplantation for non-malignant diseases.Hydroxycarbamine: from an Old Drug Used in Malignant Hemopathies to a Current Standard in Sickle Cell Disease.Stem-cell transplantation in children and adults with sickle cell disease: an update.Genetic strategies for the treatment of sickle cell anaemia.Sickle cell nephropathy - a practical approach.Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'.Conditioning regimens in allo-SCT for thalassemia major.Management of sickle cell disease in the community.Themes reported by families as important when proceeding with pediatric hematopoietic stem cell transplantation.Acute pain crisis in a patient with sickle cell disease undergoing ovarian simulation for fertility preservation prior to curative stem cell transplantation: case report and literature review.Natural Remedies for the Treatment of Beta-Thalassemia and Sickle Cell Anemia-Current Status and Perspectives in Fetal Hemoglobin Reactivation.Favorable outcomes after in utero transfusion in fetuses with alpha thalassemia major: a case series and review of the literature.Hematopoietic stem cell transplantation from non-sibling matched family donors for patients with thalassemia major in Jordan.Health-related quality of life after allogeneic hematopoietic stem cell transplantation for sickle cell disease.Enhanced Long-Term Brain Magnetic Resonance Imaging Evaluation of Children with Sickle Cell Disease after Hematopoietic Cell Transplantation.Deferasirox use after hematopoietic stem cell transplantation in pediatric patients with beta-thalassemia major: preliminary results.Outcome of invasive mechanical ventilation after pediatric allogeneic hematopoietic SCT: results from a prospective, multicenter registry.Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major.Novel dominant β-thalassemia: Hb Boston-Kuwait [codon 139/140(+T)].
P2860
Q28088552-12FC0BA9-844C-42A4-9533-9E18C9A9727FQ28652702-7D377DFE-37CF-46CC-BD60-1B57604EABA0Q31116644-62023EA7-F7A6-4D00-B4D2-B58348CA59A0Q33718497-44FC533B-36A0-47E8-8707-D1C941055B63Q33842493-B0018608-A736-405E-85CF-FA07472D687FQ33937843-1FF385B2-2212-43A0-A4AD-D9640B2C68BEQ34120772-4CB8C59D-FE11-4E9B-A0A0-CE6E6917410BQ34336920-C88A74A3-5E3F-4504-B6F6-8DC03D0490C3Q34707143-4CFBA30D-18EE-426C-B744-0B854C137FD4Q34824419-C554E1C0-0A8F-4076-AEE1-7DB2ED86880BQ34824540-E074D16F-9307-422E-BF1D-CA0B844F3904Q34976550-8523D0F4-98BB-4227-B838-E7704923FEA3Q35683885-5C51AC4C-2F6A-4259-9E51-03C4934E7C4FQ35777496-FD23B7E0-5C3C-4F04-BB2C-49F0D5980680Q35986327-DE5DD1BE-0BD4-4446-97CD-D345FDC3FE51Q36341652-44458AE7-60B8-4B22-8800-B4E95E66E273Q37328417-D951343E-D9EF-4CE8-A841-F5CB2AD7499AQ37351058-487558AE-66FE-4C05-B04C-CF2A0AED4C2BQ37607972-7370045E-A436-48EC-A611-EAC4FE107888Q37677221-8B915812-04F6-4D25-93C7-085FE404342DQ37888719-D4881213-8B09-4627-B7EA-7DA162633618Q37894826-1C25DEDE-6949-4008-A2B4-9EFF39ADCC31Q37929278-83FEEC2F-5E7E-4EA4-89C3-3FAF85D199F1Q37969631-D2575598-9494-4E1A-9347-A629A82B4189Q38179977-CDC51947-2B01-4606-AD68-6135B957C14DQ38194789-60D8FCF8-1A33-4E47-9214-68B838047883Q38430937-B619AB66-513C-4224-9C66-9F67F9F27DDBQ38643563-B0ECA223-4158-411E-855B-61F9687B219FQ38879274-3431B34F-6BBF-4082-9153-5D2056970059Q39012921-067ECC07-4B89-4721-B17A-152FA2A2D8D0Q40401388-38F9432F-CAA6-4DF5-99A0-A64982654409Q41592113-A8FFECBA-637D-4CD9-A9C0-EA8DB68F2951Q41719695-4666EBEC-FA16-499A-B731-A7ED01A5B1BDQ42976189-41705CBE-F72D-4537-BA53-EFC74D3FE0C2Q43786568-02C42E85-CEC8-415E-9D35-D93CD12CDCEFQ50105348-9F816625-52DD-4566-8F9B-578C8F9DE64AQ50898967-DB3BD751-0F8D-4291-AF30-49327C90DD51
P2860
Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hematopoietic cell transplanta ...... ase: past, present and future.
@en
Hematopoietic cell transplanta ...... ase: past, present and future.
@nl
type
label
Hematopoietic cell transplanta ...... ase: past, present and future.
@en
Hematopoietic cell transplanta ...... ase: past, present and future.
@nl
prefLabel
Hematopoietic cell transplanta ...... ase: past, present and future.
@en
Hematopoietic cell transplanta ...... ase: past, present and future.
@nl
P2860
P356
P1476
Hematopoietic cell transplanta ...... ase: past, present and future.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BMT.1705943
P407
P577
2007-12-03T00:00:00Z